TGINSIGHT SIMILAR POSTS
Source channel @githubtrending · Post #14839 · Jun 18
#typescript#alibaba#low_code#lowcode Low-code platforms like LowCodeEngine help you build applications quickly without needing to write a lot of code. This means you can create and deploy apps faster, which is good for businesses because they can respond quickly to changing needs. Low-code platforms also make it easier to update apps and improve user experience. They provide tools and components that simplify development, allowing developers to focus on more complex tasks and innovations. This approach helps prevent technical debt and supports better decision-making by providing real-time data insights[1][3][4]. https://github.com/alibaba/lowcode-engine
Search: #vets
@vetplusacademy · Post #1291 · 01/29/2026, 03:42 PM
¡Tu crecimiento profesional no se detiene! 📈 Estamos diseñando un espacio donde la teoría y la práctica se encuentran para fortalecer tus competencias clínicas. Guías descargables, sesiones en vivo y certificación mensual son solo el comienzo. Mantente conectado. Lo que viene superará tus expectativas ✨ 🌐 Visítanos: vetplusacademy.com 📲 WhatsApp: +58 414 5300397 #VetPlus#Vets#MedVet#EstudiantesVeterinaria#VetPlusUltra
@vets_hub · Post #30254 · 12/07/2025, 03:32 AM
ＡＲＴＩＣＬＥ 🔸𝗛𝗼𝘄 𝘁𝗼 𝗮𝗰𝗰𝘂𝗿𝗮𝘁𝗲𝗹𝘆 𝗺𝗲𝗮𝘀𝘂𝗿𝗲 𝗯𝗹𝗼𝗼𝗱 𝗽𝗿𝗲𝘀𝘀𝘂𝗿𝗲 🐕🐈🩸 #pets#canine#dogs#feline#cats#vets#veterinarians#bloodpressure#dvm
@vets_hub · Post #30253 · 12/07/2025, 03:32 AM
ＡＲＴＩＣＬＥ 🔸𝗣𝘆𝗼𝗻𝗲𝗽𝗵𝗿𝗼𝘀𝗶𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗖𝗮𝘁 𝗮𝗻𝗱 𝗗𝗼𝗴 #canine#feline#dogs#cats#pets#vets#veterinarians#veterinarypractice#dvm
@vets_hub · Post #30255 · 12/07/2025, 03:32 AM
ＮＥＷＳ 🔻𝗪𝗲𝗶𝗴𝗵𝘁 𝗹𝗼𝘀𝘀 𝗱𝗿𝘂𝗴𝘀 𝗳𝗼𝗿 𝗰𝗮𝘁𝘀? 𝗖𝗼𝗺𝗽𝗮𝗻𝘆 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗶𝗺𝗽𝗹𝗮𝗻𝘁𝘀 𝗶𝗻 𝗰𝗮𝘁𝘀 #Okava_Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new #GLP_1 clinical weight loss study for cats. #MEOW_1, as the study is called, will look to use #OKV_119, a miniature implant, in cats which will deliver the GLP-1, continuously for up to six months. According to #Okava, MEOW-1 is the first-ever weight loss trial using this approach on household pets. Klotsman said the goal would be to file for #FDA approval for the product between 2027 and 2028, and the target is for the product to cost owners an out-of-pocket payment of around $100 per month. Read the full story 👇 https://abcnews.go.com/GMA/Wellness/weight-loss-drugs-cats-company-launches-clinical-trial/story?id=128054236 #feline#cats#pets#petobesity#petcare#okavapharmaceuticals#sanfrancisco#vets#petowners#veterinarians#dvm